Rural Health
Resources by Topic: Illicit drug use
Illegally Made Fentanyl Use in the United States: 2022 and 2023
Report highlights findings from the 2022 and 2023 National Survey on Drug Use and Health (NSDUH) on the use of illegally made fentanyl across the U.S. Explores co-usage with other drugs, emergency room visits/hospitalizations, and breaks down user characteristics by age, poverty level, and rurality, among other measures.
Citation: NSDUH Data Brief, 2(2)
Date: 07/2025
Sponsoring organizations: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration
view details
Report highlights findings from the 2022 and 2023 National Survey on Drug Use and Health (NSDUH) on the use of illegally made fentanyl across the U.S. Explores co-usage with other drugs, emergency room visits/hospitalizations, and breaks down user characteristics by age, poverty level, and rurality, among other measures.
Citation: NSDUH Data Brief, 2(2)
Date: 07/2025
Sponsoring organizations: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration
view details
Evaluation of the Maternal Opioid Misuse (MOM) Model: Fourth Annual Report (Implementation Year 3)
Provides an overview of the Maternal Opioid Misuse Model, which provides evidence-based integrated care and care coordination for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD). Describes activities MOM Model awardees undertook during the MOM Model's second implementation year, July 1, 2023–June 30, 2024, and summarizes qualitative and beneficiary-level process data findings by state awardee. Discusses barriers pregnant and postpartum women with OUD face in accessing high-quality, continuous care, specifically in rural areas.
Additional links: Findings at a Glance
Date: 06/2025
Sponsoring organizations: Centers for Medicare and Medicaid Services, Westat
view details
Provides an overview of the Maternal Opioid Misuse Model, which provides evidence-based integrated care and care coordination for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD). Describes activities MOM Model awardees undertook during the MOM Model's second implementation year, July 1, 2023–June 30, 2024, and summarizes qualitative and beneficiary-level process data findings by state awardee. Discusses barriers pregnant and postpartum women with OUD face in accessing high-quality, continuous care, specifically in rural areas.
Additional links: Findings at a Glance
Date: 06/2025
Sponsoring organizations: Centers for Medicare and Medicaid Services, Westat
view details
The Opioid Epidemic in Rural Communities: Can Telehealth Increase Access to Medication for Opioid Use Disorder and Offset Barriers to Care?
Examines the impact of telehealth on access to medication for opioid use disorder (MOUD) and substance and opioid use disorder (SUD/OUD) treatment. Utilizes data from the Rural Communities Opioid Response Program's (RCORP) consortia, the National Survey of Drug Use and Health (NSDUH), and the U.S. Census Bureau's American Community Survey (ACS) to analyze access to MOUD and rates of telehealth use for rural consortia. Discusses potential barriers and factors impacting telehealth implementation for SUD/OUD care.
Author(s): Kathleen Meyers, Shannon Herman, Heather Schuler, et al.
Citation: Drug and Alcohol Dependence, 271, 112628
Date: 06/2025
view details
Examines the impact of telehealth on access to medication for opioid use disorder (MOUD) and substance and opioid use disorder (SUD/OUD) treatment. Utilizes data from the Rural Communities Opioid Response Program's (RCORP) consortia, the National Survey of Drug Use and Health (NSDUH), and the U.S. Census Bureau's American Community Survey (ACS) to analyze access to MOUD and rates of telehealth use for rural consortia. Discusses potential barriers and factors impacting telehealth implementation for SUD/OUD care.
Author(s): Kathleen Meyers, Shannon Herman, Heather Schuler, et al.
Citation: Drug and Alcohol Dependence, 271, 112628
Date: 06/2025
view details
Discreet but Accessible: A Qualitative Study with People Who Use Drugs and Service Staff about the Optimal Design of a Harm Reduction Vending Machine in Rural Kentucky
Analyzes perspectives on harm reduction vending machine (HRVM) access and suitability via interviews with people who use drugs as well as health department and syringe service program (SSP) staff in rural Appalachian Kentucky. Discusses factors influencing the usefulness of HRVMs and their ability to address public health needs such as infectious disease prevention, overdose reduction, and other community benefits.
Author(s): Rachel M. Marschke, April M. Young, Hannah K. Knudsen, Chelsi N. Cheatom, Hannah L. F. Cooper
Citation: Harm Reduction Journal, 22, 88
Date: 05/2025
view details
Analyzes perspectives on harm reduction vending machine (HRVM) access and suitability via interviews with people who use drugs as well as health department and syringe service program (SSP) staff in rural Appalachian Kentucky. Discusses factors influencing the usefulness of HRVMs and their ability to address public health needs such as infectious disease prevention, overdose reduction, and other community benefits.
Author(s): Rachel M. Marschke, April M. Young, Hannah K. Knudsen, Chelsi N. Cheatom, Hannah L. F. Cooper
Citation: Harm Reduction Journal, 22, 88
Date: 05/2025
view details
Rural Access to Certified Community Behavioral Health Clinics (CCBHCs)
Examines access to, and services offered by, Certified Community Behavioral Health Clinics (CCBHCs) in rural and urban communities. Also compares services at CCBHCs with those offered at other mental health clinics. Features state-level maps showing CCBHC counts by state, and statistics on services counts in CCBHCs and other mental health facilities, with breakdowns by urban and rural areas.
Author(s): Aaron P. Smith, Jeffrey Talbert
Date: 05/2025
Sponsoring organization: Rural and Underserved Health Research Center
view details
Examines access to, and services offered by, Certified Community Behavioral Health Clinics (CCBHCs) in rural and urban communities. Also compares services at CCBHCs with those offered at other mental health clinics. Features state-level maps showing CCBHC counts by state, and statistics on services counts in CCBHCs and other mental health facilities, with breakdowns by urban and rural areas.
Author(s): Aaron P. Smith, Jeffrey Talbert
Date: 05/2025
Sponsoring organization: Rural and Underserved Health Research Center
view details
Reported Rural Drug Overdoses Decline 40 Percent in One Year (Pennsylvania)
Compares rates of drug overdoses in 2023 and 2024 in rural and urban areas of Pennsylvania. Features statistics on reported drug overdose rates per 100,000 during these years, percent of rural and urban residents receiving Naloxone in 2023 and 2024, demographic information on rural overdose victims, and a county-level map showing percent change in reported overdoses by county.
Date: 05/2025
Sponsoring organization: Center for Rural Pennsylvania
view details
Compares rates of drug overdoses in 2023 and 2024 in rural and urban areas of Pennsylvania. Features statistics on reported drug overdose rates per 100,000 during these years, percent of rural and urban residents receiving Naloxone in 2023 and 2024, demographic information on rural overdose victims, and a county-level map showing percent change in reported overdoses by county.
Date: 05/2025
Sponsoring organization: Center for Rural Pennsylvania
view details
Opioid Stewardship Programs in Rural Arizona
Provides an overview of Opioid Stewardship Programs (OSPs), and discusses OSP implementation and knowledge in Arizona from a survey of 39 Arizona rural hospital leaders and professionals. Includes an infographic on the results of the OSP survey and links to OSP training resources.
Author(s): Bridget S. Murphy
Date: 04/2025
Sponsoring organization: Arizona Center for Rural Health
view details
Provides an overview of Opioid Stewardship Programs (OSPs), and discusses OSP implementation and knowledge in Arizona from a survey of 39 Arizona rural hospital leaders and professionals. Includes an infographic on the results of the OSP survey and links to OSP training resources.
Author(s): Bridget S. Murphy
Date: 04/2025
Sponsoring organization: Arizona Center for Rural Health
view details
Controlled Substance Prescribing Patterns Among Fatal Overdose Decedents with an Opioid, Stimulant, or Both Contributing to Death — Pennsylvania, 2017–2022
Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.
Author(s): Stephanie Hayden, Stanley M. Murzynski, Ashley Bolton, Carrie Thomas Goetz
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209
Date: 04/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.
Author(s): Stephanie Hayden, Stanley M. Murzynski, Ashley Bolton, Carrie Thomas Goetz
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209
Date: 04/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
The Rural and Urban Supply of Clinicians With a DEA Waiver to Prescribe Buprenorphine in 2022 Prior to the Elimination of the Waiver Requirement
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date: 04/2025
Sponsoring organization: WWAMI Rural Health Research Center
view details
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date: 04/2025
Sponsoring organization: WWAMI Rural Health Research Center
view details
Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs
Examines availability of methadone at opioid treatment programs for Medicare beneficiaries who have been diagnosed with an opioid use disorder. Utilizes data from 640,706 Medicare beneficiaries and analyzes their respective drive time to a treatment facility as well as receipt of methadone treatment. Includes U.S. map showing locations of opioid treatment programs and rural versus urban comparisons of patient drive times.
Author(s): Jonathan Cantor, Helin G. Hernandez, Aaron Kofner, et al.
Citation: JAMA Network Open, 8(4)
Date: 04/2025
view details
Examines availability of methadone at opioid treatment programs for Medicare beneficiaries who have been diagnosed with an opioid use disorder. Utilizes data from 640,706 Medicare beneficiaries and analyzes their respective drive time to a treatment facility as well as receipt of methadone treatment. Includes U.S. map showing locations of opioid treatment programs and rural versus urban comparisons of patient drive times.
Author(s): Jonathan Cantor, Helin G. Hernandez, Aaron Kofner, et al.
Citation: JAMA Network Open, 8(4)
Date: 04/2025
view details